Triangle Securities Wealth Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.84M Sell
19,048
-208
-1% -$48.5K 0.96% 32
2026
Q1
$4.71M Buy
19,256
+162
+0.8% +$37.7K 1.07% 26
2025
Q4
$3.95M Sell
19,094
-266
-1% -$52.6K 0.83% 35
2025
Q3
$3.59M Buy
19,360
+1,611
+9% +$276K 0.81% 35
2025
Q2
$2.71M Sell
17,749
-2,116
-11% -$325K 0.67% 45
2025
Q1
$3.29M Sell
19,865
-131
-0.7% -$20.5K 0.85% 34
2024
Q4
$2.89M Sell
19,996
-244
-1% -$37.8K 0.74% 34
2024
Q3
$3.28M Sell
20,240
-983
-5% -$157K 0.85% 31
2024
Q2
$3.1M Buy
21,223
+1,538
+8% +$229K 0.88% 30
2024
Q1
$3.11M Buy
19,685
+286
+1% +$45.5K 0.89% 28
2023
Q4
$3.04M Buy
19,399
+84
+0.4% +$12.9K 0.95% 25
2023
Q3
$3.01M Buy
19,315
+29
+0.2% +$4.79K 1.07% 23
2023
Q2
$3.19M Sell
19,286
-84
-0.4% -$13.6K 1.1% 21
2023
Q1
$3M Sell
19,370
-99
-0.5% -$16K 1.07% 22
2022
Q4
$3.44M Sell
19,469
-132
-0.7% -$22.8K 1.26% 19
2022
Q3
$3.2M Sell
19,601
-246
-1% -$41.6K 1.31% 20
2022
Q2
$3.52M Sell
19,847
-185
-0.9% -$33K 1.37% 15
2022
Q1
$3.55M Sell
20,032
-385
-2% -$65.5K 1.19% 18
2021
Q4
$3.49M Sell
20,417
-175
-0.8% -$28.6K 1.09% 20
2021
Q3
$3.33M Sell
20,592
-64
-0.3% -$10.9K 1.13% 20
2021
Q2
$3.4M Sell
20,656
-100
-0.5% -$16.6K 1.15% 20
2021
Q1
$3.41M Buy
20,756
+441
+2% +$71.4K 1.23% 16
2020
Q4
$3.2M Sell
20,315
-1,039
-5% -$153K 1.27% 17
2020
Q3
$3.18M Sell
21,354
-784
-4% -$116K 1.44% 12
2020
Q2
$3.11M Sell
22,138
-1,033
-4% -$151K 1.49% 13
2020
Q1
$3.04M Buy
23,171
+112
+0.5% +$15.9K 1.75% 9
2019
Q4
$3.36M Sell
23,059
-391
-2% -$53K 1.46% 16
2019
Q3
$3.03M Sell
23,450
-459
-2% -$60.5K 1.48% 20
2019
Q2
$3.37M Sell
23,909
-478
-2% -$66.2K 1.71% 13
2019
Q1
$3.41M Sell
24,387
-629
-3% -$84.3K 1.79% 10
2018
Q4
$3.23M Sell
25,016
-48
-0.2% -$6.7K 1.91% 9
2018
Q3
$3.46M Sell
25,064
-546
-2% -$72.6K 1.84% 9
2018
Q2
$3.11M Sell
25,610
-325
-1% -$40.5K 1.74% 9
2018
Q1
$3.32M Sell
25,935
-1,034
-4% -$140K 1.91% 9
2017
Q4
$3.77M Sell
26,969
-513
-2% -$71.5K 2.15% 6
2017
Q3
$3.57M Sell
27,482
-450
-2% -$59.7K 2.13% 5
2017
Q2
$3.69M Sell
27,932
-425
-1% -$54.2K 2.44% 4
2017
Q1
$3.53M Buy
28,357
+327
+1% +$39.1K 2.25% 5
2016
Q4
$3.23M Sell
28,030
-919
-3% -$106K 2.16% 6
2016
Q3
$3.42M Sell
28,949
-1,291
-4% -$157K 2.37% 5
2016
Q2
$3.67M Sell
30,240
-3,201
-10% -$364K 2.74% 4
2016
Q1
$3.62M Sell
33,441
-215
-0.6% -$22.3K 2.36% 5
2015
Q4
$3.46M Sell
33,656
-24
-0.1% -$2.41K 2.32% 7
2015
Q3
$3.14M Sell
33,680
-563
-2% -$54.5K 2.38% 6
2015
Q2
$3.34M Hold
34,243
2.36% 7
2015
Q1
$3.44M Buy
34,243
+461
+1% +$46.9K 2.39% 7
2014
Q4
$3.53M Sell
33,782
-548
-2% -$57.8K 2.51% 6
2014
Q3
$3.66M Sell
34,330
-40
-0.1% -$4.15K 2.81% 4
2014
Q2
$3.6M Sell
34,370
-1,639
-5% -$166K 2.76% 4
2014
Q1
$2.94M Buy
36,009
+1,817
+5% +$168K 2.64% 5
2013
Q4
$3.13M Sell
34,192
-368
-1% -$33.9K 2.54% 5
2013
Q3
$3M Sell
34,560
-988
-3% -$88.6K 2.61% 5
2013
Q2
$3.05M Buy
+35,548
New +$3.02M 2.26% 4

Other funds holding JNJ

Triangle Securities Wealth Management's JNJ Position: Q2 2026 in Review

Triangle Securities Wealth Management reduced its Johnson & Johnson (JNJ) stake by 1.1% in Q2 2026, selling an estimated $48.5K and leaving 19,048 shares worth $4.84M. The position accounts for 0.96% of the portfolio, ranked #32.

Triangle Securities Wealth Management first reported a position in JNJ in Q2 2013 and has held it in 53 quarters since. 1,028 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Triangle Securities Wealth Management held 19,048 shares of Johnson & Johnson worth $4.84M as of Q2 2026.
  • Triangle Securities Wealth Management sold 208 Johnson & Johnson shares in Q2 2026, an estimated $48.5K.
  • Johnson & Johnson made up 0.96% of Triangle Securities Wealth Management's portfolio in Q2 2026, its #32 holding.
  • Triangle Securities Wealth Management first reported a position in Johnson & Johnson in Q2 2013 and has held it in 53 quarters since.
  • 1,028 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Triangle Securities Wealth Management's 13F filing for Q2 2026, filed 14 Jul 2026.